Supplementary Figure S5

Slides:

Advertisements

Similar presentations

Somatic Mutation Distributions Determining Cut-offs Supp. Figure 5.

Advertisements

A Colonscope is used to remove or biopsy polyps  Night Prep.

Rate of breast cancer-specific survival Months Low gene expression (N=252) High gene expression (N=37) P < (Log-rank) a Months Low gene expression.

Cancer “whiteboard” presentation ●Name of cancer (what type), where can it occur? ●Function of body part that it affects ●Causes (genetic, environmental…)?

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer Victor E. Chen, BS, Erin.

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Volume 12, Issue 9, Pages (September 2011)

Su K. Metcalfe, MD, MPH, Michael T

Supplementary Figure 1. Importance of first neighbours in breast cancer, hepatocellular carcinoma and non-small cell lung cancer in the SignaLink network.

Validation of late-type genes

Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract Noah Switzer, Andrew Lim, Lillian Du,

Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive.

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Volume 18, Issue 6, Pages e1 (November 2017)

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung Sai-Hong.

Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis Ian Cromwell, MSc, Kimberly.

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis Yi-Jhih.

EMT correlates with PERK but not IRE1 signaling in primary human tumors. EMT correlates with PERK but not IRE1 signaling in primary human tumors. A, two.

سرطان الثدي Breast Cancer

A B C Supplementary figure S7

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database Alex.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database Alex.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

FLAG β-actin p53 SET M.w. kDa D β-actin p53 G9a

Joe West, Richard F.A Logan, Tim R Card, Chris Smith, Richard Hubbard

Shih-Jen Hwang, Guillermina Lozano, Christopher I. Amos, Louise C

Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract Noah Switzer, Andrew Lim, Lillian Du,

Survival after resection of synchronous non–small cell lung cancer

Lung transplantation for primary and secondary pulmonary hypertension

Is obesity a risk factor for cirrhosis-related death or hospitalization? a population-based cohort study George N Ioannou, Noel S Weiss, Kris V Kowdley,

Meta-analysis of all patients

Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort Leah Backhus, MD, Jonathon Sargent, BS, Aaron.

A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening.

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation.

Melanie H. Jacobson, M. P. H. , Ann C. Mertens, Ph. D. , Jessica B

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Volume 7, Issue 11, (November 2010)

Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green

Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD

Does Granulocyte Colony–Stimulating Factor Affect Survival in Patients with Advanced Non-small Cell Lung Cancer? Goulnar Kasymjanova, MD, Harvey Kreisman,

Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.

PD-L1 as a Companion Biomarker for Immune Checkpoint Inhibitors in NSCLC: Should RNA ISH (RISH) Be Considered? Steven G. Gray, PhD Journal of Thoracic.

Prolonged Survival in Patients with Lung Cancer with Diabetes Mellitus

Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304) Gregory A. Otterson,

Impact of a Multidisciplinary Thoracic Oncology Clinic on the Timeliness of Care Richard F. Riedel, MD, Xiaofei Wang, PhD, Meg McCormack, PA-C, Eric Toloza,

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases Hironori Uruga, MD, PhD, Emine Bozkurtlar,

Clinical Relevance of Our Multimodality Prognostic Score

3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective.

It’s All in the “Swerve of the Curve”

Supplementary Figure S3

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Clinical Lymphoma, Myeloma and Leukemia

Supplementary Figure S1

Expression of RUNX2 correlates with ER/PR/HER2-negative human breast cancer. Expression of RUNX2 correlates with ER/PR/HER2-negative human breast cancer.

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

National data in surgery: LCCOP 2018(2016)

Overview of cancer genetics in the SMP1 cohort: lung cancer (A), breast cancer (B), colorectal adenocarcinoma (except mucinous subtype) (C), prostate cancer.

Kaplan-Meier curves for PFS (panel A) and OS (panel B) of patients with mTCC receiving an anti-EGFR based therapy. mTCC, metastatic transverse colon cancer;

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.

Scatter plot of serum OPN levels and its correlation with patient survival. Scatter plot of serum OPN levels and its correlation with patient survival.

Figure Prevalence of coronary artery disease by year or

Xuan Bich Trinh, M. D. , Wiebren A. A. Tjalma, M. D. , Ph. D. , Amin P

Node-Negative Non-small Cell Lung Cancer: Pathological Staging and Survival in 1765 Consecutive Cases Benjamin M. Robinson, BSc, MBBS, Catherine Kennedy,

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Supplementary Figure S5 Cohorts 1: Positive correlation Cohorts 2: Negative or no correlation Kaplan-Meier survival analysis Chronic lymphocytic leukemia (GSE39671) Corr.= -0.23 p= 0.0085 Corr.=0.50 B Breast cancer (GSE25055) Corr.= -0.4 p= 0.0157 Corr.=0.70 C Corr.= -0.47 Breast cancer (GSE17705) p= 0.0273 Corr.=0.75 D Corr.= -0.53 Breast cancer (GSE11121) Corr.=0.66 p= 0.0278 E Breast cancer (GSE3494 ) p= 0.0403 Corr.=0.65 Corr.= -0.58

F G H Cohorts 1: Positive correlation Cohorts 2: Negative or no correlation Kaplan-Meier Survival Analysis F Ovarian Cancer (GSE17260) Corr.=0.82 Corr.= -0.86 p= 0.0414 G Colon cancer (GSE17538) Corr.=0.68 Corr.= -0.48 p= 0.0428 H Lung cancer (GSE31210) Corr.=0.84 Corr.= -0.38 p= 0.0436